Deerfield Management Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+33
n/a
$25.0M
($10.0M - $50.0M)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+16
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
Photo of James Flynn, Managing Partner at Deerfield Management
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+20
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+17
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+16
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York City
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+24
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Health IT (Series B)
+14
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
+21
n/a
$25.0M
($10.0M - $50.0M)
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Enterprise (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Enterprise (Seed)
+4